Why the study?
Does catheter ablation without fluoroscopy using 3D mapping safely treat supraventricular tachycardia in pregnant women?
Does catheter ablation without fluoroscopy using 3D mapping safely treat supraventricular tachycardia in pregnant women?
Three-dimensional mapping enables safe, fluoroscopy-free catheter ablation of supraventricular tachycardia during pregnancy, avoiding radiation exposure to the fetus.
Answers are grounded in this paper and cite their sources.
Does not support routine fluoroscopy-free ablation in pregnancy; leaves open need for prospective safety data.
BACKGROUND: Although uncommon, supraventricular tachycardia is difficult to manage during pregnancy. Catheter ablation traditionally has been deferred owing to radiation exposure risks. Three-dimensional mapping is a new tool in cardiac electrophysiology, which is being utilized to eliminate fluoroscopy during catheter ablation. We report a case of ablation of supraventricular tachycardia during pregnancy without using fluoroscopy. CASE: A 27-year-old woman with a 22-week twin gestation was referred for incessant supraventricular tachycardia. Medical management with propranolol and flecainide was unsuccessful. An electrophysiology study was performed with catheter navigation guided by a three-dimensional mapping system instead of fluoroscopy. The patient underwent successful cryoablation. The procedure was performed without fluoroscopy or sedation. The patient delivered healthy twins at 35 weeks of gestation without complications. On follow-up at 26 months, she showed no evidence of recurrence. CONCLUSION: New tools in electrophysiology now make curative procedures more readily available to pregnant women and safer for the fetus.
No takes yet. Share an insight, caveat, or question.
Bigelow et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: